CLPT
$11.16
ClearPoint Neuro, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventi...
Recent News
ClearPoint Neuro (CLPT) Earnings Call Transcript
Joseph Burnett: Thank you. This is one of the largest unmet needs in all of medicine, and we at ClearPoint Neuro, Inc. believe we can play a crucial role in this exciting future. This foundation is made up of four growing product categories, a vetted pipeline of new development programs, an expanded manufacturing footprint, a thoroughly audited quality system, a collection of global regulatory approvals, an expansive IP portfolio, an installed base of more than 150 global centers, and the cash position and investor base to execute on our strategy.
ClearPoint Neuro Inc (CLPT) Q4 2025 Earnings Report Preview: What To Expect
The consensus estimate for Q4 2025 revenue is $10.05 million, and the earnings are expected to come in at -$0.20 per share. The full year 2025's revenue is expected to be $36.60 million, and the earnings are expected to be -$0.83 per share. More detailed estimate data can be found on the Forecast page.
ClearPoint Neuro (CLPT) Moves 8.1% Higher: Will This Strength Last?
ClearPoint Neuro (CLPT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
How The ClearPoint Neuro (CLPT) Investment Story Is Shifting After FDA Feedback And Valuation Cut
ClearPoint Neuro is back in focus after analysts cut their price target from US$28 to US$18, while also lowering their fair value estimate from US$29 to US$24. The move reflects a mix of optimism around more than 60 biopharma partners and six clinical stage intracranial programs, set against higher perceived risk following recent FDA feedback and related share price pressure. As you read on, you will see what is driving this evolving narrative and how to keep track of the moving...
CLPT Gets EU MDR Certification for ClearPoint Navigation Software
ClearPoint secures EU MDR certification for ClearPoint Navigation Software 3.0.2, expanding precision-guided surgery access across MRI suites and operating rooms.